Fiber before surgery: could a diet change improve colon cancer outcomes?
NCT ID NCT06212817
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether it's possible to increase fiber intake in people with colorectal cancer before they have surgery. Researchers will compare personalized digital dietary advice, a dried vegetable product, and usual diet in 54 participants. The goal is to see if fiber intake changes and if it affects bowel habits and gut symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dietary fiber (via personalized advice or dried vegetable product)
- What this could lead to
- If successful, this could show that boosting fiber before surgery is practical and may help with bowel function and symptoms.
- What could go wrong
- This is a small feasibility study, not designed to prove clinical benefit. Results may not change standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Meander Medisch Centrum
RECRUITINGAmersfoort, Utrecht, Netherlands
-
Rijnstate
RECRUITINGArnhem, Gelderland, Netherlands
-
Ziekenhuis Gelderse Vallei
RECRUITINGEde, Gelderland, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?